SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-072880
Filing Date
2024-06-18
Accepted
2024-06-18 17:00:33
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417520-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417520-2_4seq1.xml 4 4335
  Complete submission text file 0001104659-24-072880.txt   5846
Mailing Address
Business Address
DRISCOLL FREDERICK W (Reporting) CIK: 0001129890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 241052763

Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)